COLUMBIA LABORATORIES, INC

Columbia Laboratories, Inc. specializes in clinical research and pharmaceutical development services, leveraging laboratory-based analytical capabilities to support regulated medical product evaluation. Their core expertise includes bioanalytical testing, pharmacokinetic and pharmacodynamic analysis, and quality control procedures aligned with FDA and GLP standards. The company applies validated methodologies for sample processing, chromatographic separation, and data integrity management in support of drug development pipelines. Technical differentiators include precision in assay validation, sample chain-of-custody protocols, and compliance with 21 CFR Part 11 for electronic records. Their operational model emphasizes reproducibility, audit readiness, and method transfer for multi-site clinical trials. Award history is not available to confirm specific agency engagements, so no definitive patterns of federal partnership can be inferred. Similarly, without recent contract data, it is not possible to identify primary federal customers or the nature of any government-funded research support. The primary NAICS code 621511 indicates focus on clinical research centers, meaning the company operates as a contracted laboratory service provider for pharmaceutical and biotech clients engaged in human clinical trials. This places them in the specialized niche of contract research organizations (CROs) supporting drug approval processes through regulated lab testing, rather than direct clinical care or diagnostic services. Columbia Laboratories, Inc. is structured as a small business under the 2L entity classification and is headquartered in Portland, Oregon. No government certifications are listed, and there is no public indication of additional locations or federal contracting credentials. Their market positioning is that of a niche laboratory services provider operating within the broader clinical research ecosystem, with capabilities oriented toward compliance-driven analytical science rather than large-scale federal program management.